Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis

• Main Authors: Haruna Yamamoto (Author), Hiroaki Ikesue (Author), Mai Ikemura (Author), Rieko Miura (Author), Kazumi Fujita (Author), Hobyung Chung (Author), Yoshiki Suginoshita (Author), Tetsuro Inokuma (Author), Tohru Hashida (Author)
• Format: Book
• Published: BMC, 2018-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Direct-acting antivirals (DAAs) are known to improve tolerability and have higher efficacy and shorter treatment durations compared with conventional interferon (IFN)-based treatments for hepatitis C virus (HCV) infection. Management of drug interactions and maintenance of patien...